Received 10/05/2022 review began 10/16/2022 review ended 10/22/2022 published 10/30/2022

HIGHLIGHTS

• who: Report et al. from the (UNIVERSITY) have published the research: Received 10/05/2022 Review began 10/16/2022 Review ended 10/22/2022 Published 10/30/2022, in the Journal: (JOURNAL) of October/30,/2022
• what: GBS may develop time linked to the first dose of SARS COV-2 Oxford/AstraZeneca vaccine.
• future: The committee suggests that more thorough investigations employing reliable study designs alternate data sources and comparisons of populations with and without vaccinations are necessary to establish the cause .

SUMMARY

Guillain-Barré syndrome (GBS) is . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.